General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Boehringer Ingelheim Pharmaceuticals, Inc(SIGNIFICANT), AstraZeneca Pharmaceuticals(MODEST), Bayer(SIGNIFICANT), Pfizer(MODEST), Sanofi/Lexicon(MODEST), Vertex Pharmaceuticals(MODEST), Anji(MODEST), Novo Nordisk Inc.(SIGNIFICANT), Eli Lilly(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Boehringer Ingelheim Pharmaceuticals, Inc(SIGNIFICANT), Merck & Co., Inc.(SIGNIFICANT), Roche(SIGNIFICANT), Bluedrop(SIGNIFICANT)

View Full Disclosure